This demonstrates, consistent with other studies, that the knockdown of PLD1 expression or blocking of PLD activity with specific inhibitors correlates with impaired (cancer) cell migration [11, 22, 30, 36, 41, 43, 58]. Here, PLD1 is linked to cancer.